Review Article
Relationship between Antibiotic Consumption and Resistance: A Systematic Review
Table 3
Distribution of correlation between ABC and antibiotic-resistant bacteria, 2016–2022 (N = 58).
| | ABC | Resistant antibiotic | Bacterial resistance to antibiotic in question (±) | | P. aeruginosa | K. pneumonia | E. coli | N. gonorrhoeae | A. baumannii | E. cloacae | MRSA | Others (11) |
| | Positive and negative correlation between ABC and rate of resistance | 73/14 | 63/14 | 68/10 | 8 | 53/9 | 12(5) | 15(11) | 29 |
| | Overall correlation between ABC and rate of resistance | 87 | 77 | 78 | 8 | 62 | 17 | 26 | 29 |
| | Carbapenem | Carbapenem | 6(2) | 8(1) | 3 | | 11 | 3 | 1 | 1 | | Levofloxacin | | | 0/1 | | | | | 0 | | Imipenem | 4(1) | | | | 2 | | | 0 | | Ceftazidime | 1 | 0/1 | | | | | | 0 | | Amikacin | | | | | | 1 | | 0 | | Fluoroquinolone | 1 | 1 | | | | | | 0 | | 3GC | | 1 | 1 | | | | | 0 | | Meropenem | 2 | | | | | | | 0 | | Ciprofloxacin | | | 0/1 | | | | | 0 |
| | Monobactam | Monobactam | | | | | | | | | | Carbapenems | | | | | 1 | 2 | | |
| | Meropenem | Meropenem | 3 | | | | 1 | | 1 | 0 | | Piperacillin/tazobactam | | | | | | | | 1 | | Carbapenems | 2 | | | | | | | 0 |
| | Cefepime/Cefotaxime | Cefepime/Cefotaxime | 1 | | 2(1) | | 2 | | | 1 |
| | Imipenem | Imipenem | 1(1) | 1 | | | 1 | | | 0 | | Meropenem | | 1 | | | | | | | | Piperacillin/tazobactam | 1 | | | | | | | | | Carbapenems | 1 | | | | | | | 0 |
| | Imipenem/cilastatin | Imipenem/cilastatin | 1 | 1 | 1 | | | | 0/1 | 0 |
| | Piperacillin/tazobactam | Piperacillin/tazobactam | 4 | | 2 | | 2 | 0/1 | 0/1 | 3 | | Imipenem | | 1 | | | | | | | | Meropenem | | 1 | | | | | | | | Aminoglycoside | | 1 | | | | | | 0 |
| | Linezolid | Linezolid | | | | | | | | 1 |
| | Fluroquinolone | Fluroquinolone | 3 | 3(1) | 5 | 1 | 1 | | | 3 | | Trimethoprim/sulfamethoxazole | | 1 | | | | | | 0 | | Levofloxacin | | | 3 | | 2 | | | 1 | | Imipenem | 1 | | | | 0/1 | | | 0 | | Ceftazidime | | 2 | | | | | | 0 | | Amikacin | | | | | | 1 | | 0 | | Carbapenem | | 0/1 | 1(1) | | | | | 1 | | Ciprofloxacin | 2(2) | 3(1) | 3(1) | 1 | 3 | 0/1 | 1(2) | 3 | | 3GC | | 1 | 2 | | | | | 0 |
| | Levofloxacin | Levofloxacin | 2 | | 1 | | 1 | | 1 | 0 | | Fluoroquinolone | 1 | 1 | 1 | | | | | 0 | | Carbapenem | | 1 | | | | | | 0 |
| | Ciprofloxacin | Ciprofloxacin | 2(1) | 2 | 3 | | 1 (1) | | | 1 | | Carbapenem | | 0/1 | | | | | | 0 | | Meropenem | | | | | 1 | | | | | Imipenem | | | | | 1 | | | | | Piperacillin/tazobactam | | | | | | | | | | Fluoroquinolone | | | 1 | | | | | 0 |
| | Norfloxacin | Norfloxacin | | | | | | | | 0 | | Carbapenem | | 0/1 | 1 | | | | | 0 |
| | Ofloxacin | Ofloxacin | | | | | | | | 0 | | Carbapenem | | 0/1 | 0/1 | | | | | 0 |
| | Beta-lactam/beta-lactamase inhibitor | Beta-lactam/beta-lactamase inhibitor | | 1 | 2 | | | | | 0 | | Carbapenem | | | 1 | | 4 | 2(1) | | 0 | | Levofloxacin | | 2 | | | | | | 0 | | Imipenem | 2 | | | | 1 | | | 0 | | Piperacillin/tazobactam | 0/1 | | | | | | | 0 | | Ceftazidime | 4 | | | | | | | 0 |
| | Amoxicillin/clavulanate | Amoxicillin/clavulanate | 1 | 1(1) | 2 | | | | 1(2) | 2 | | 3GC | | 1 | | | | | | 0 |
| | Cephalosporin | Cephalosporin | 1 | 7(1) | 7 | 1 | 1 | | 2 | 0 | | Amoxicillin/clavulanate | | | 1 | | | | | 0 | | Trimethoprim/sulfamethoxazole | | | 1 | | | | | 0 | | Levofloxacin | | 1 | | | 1 | | | 0 | | 3GC | | 1 | 2 | | | | | 0 | | Ciprofloxacin | | | | 1 | | | | 0 | | Carbapenem | | 1 | | | 3 | | | 0 | | Piperacillin/tazobactam | 2 | 0/1 | | | | | | 0 | | Cefotaxime | | | 2 | | | | | | | Cefepime | 0/1 | 2 | 2(1) | | | | | | | Ceftazidime | | 0/1 | | | | | | 0 |
| | Aminoglycosides | Aminoglycosides | 1 | | | | 2(2) | | 0/1 | 0 | | 3GC | | 1(1) | 1(1) | | | | | 0 | | Ciprofloxacin | | | 1(1) | 1 | | | | 0 | | Imipenem | 1 | | | | 1 | | | 0 | | Ceftazidime | | 1 | | | | | | 0 | | Amikacin | 2 | | | | | 1 | | 0 | | Gentamicin | 2 | | | | | | | 0 | | Carbapenems | 1 | | | | | | | 0 |
| | Macrolides | Macrolides | | | | 1 | | | | 2 | | Cefixime | | | | 1 | | | | 0 | | Ciprofloxacin | | | | 1 | | | | 0 | | Clarithromycin | | | | | | | | 2 |
| | Tigecycline | Tigecycline | | | | | 1 | | | 0 | | Piperacillin/tazobactam | 0/1 | | | | | | | 0 |
| | Amikacin | Amikacin | 3(2) | | | | 0/1 | | | 0 | | Aminoglycosides | 1 | | | | | | | 0 | | Imipenem | 1 (1) | | | | 0/1 | | | 0 | | Meropenem | | | | | 0/1 | | | 0 |
| | Gentamicin | Gentamicin | 1 | 1(1) | 1 | | 1 | | | 1 | | Aminoglycosides | 1 | | | | | | | 0 |
| | Fosfomycin | Fosfomycin | | | 1 | | 1 | | | 0 |
| | Oxacephems | Oxacephems | | | | | 1 | | | 0 | | Levofloxacin | | | 1 | | | | | 0 | | Imipenem | 2 | | | | 0/1 | | | 0 | | Ceftazidime | | 1 | | | | | | 0 |
| | Sulfonamides | Sulfonamides | | 2 | 2 | | | | 1 | 0 | | Imipenem | 1 | | | | | | | 0 | | Ceftazidime | | 1 | | | | | | 0 |
| | All antibiotics | All antibiotics | | 1 | 1 | | | 1 | | 2 | | Fluoroquinolone | | 1 | 1 | | 1 | | | 0 | | Levofloxacin | | | 1 | | | | | 0 | | 3GC | | 1 | 1 | | | | | 0 | | Carbapenem | | 1 | 1 | | | | | 0 | | Cloxacillin | | | | | | | 1 | 0 | | Macrolides | | | | | | | | 1 |
| | β-Lactam antibiotics | β-Lactam antibiotics | | 1 | | | | | | 0 | | 3GC | | 2 | 1 | | | | | 0 | | Carbapenem | 1 | 1 | | | | | | 0 |
| | Cloxacillin | Cloxacillin | | | | | | | 1 | 0 |
| | Tetracycline | Tetracycline | | | | | | | | 0 | | Fluoroquinolone | | | 1 | | | | | 0 | | Nalidixic acid | | | 1 | | | | | 0 | | Carbapenem | | | | | 1 | | | 0 |
| | Ceftazidime | Ceftazidime | 1 | | | | | | | | | Imipenem | | | | | 1 | | | | | Meropenem | 1 | | | | 1 | | | |
| | Glycopeptides | Glycopeptides | 1 | | | | | 1 | 0/2 | 1 | | Amikacin | | | 0/1 | | 0/1 | 0/1 | | 0 | | Gentamicin | | | | | | 0/1 | 1(1) | 3 | | Carbapenem | | 1 | | | 1 | | | | | Piperacillin/tazobactam | 1 | | | | | | 1 | 0 | | Extended-spectrum cephalosporin | | | 1 | | | | | | | Amikacin | 1 | | 1 | | 1 | | | 1 | | Oxacillin | | | | | | | 1 | 0 |
| | Others | | | | 1 | | | | 2 (1) | 0 |
|
|
3GC: third-generation cephalosporins.
|